Upperton Pharma Solutions, a front-running Contract Development and Manufacturing Organisation (CDMO) in the UK, has disclosed a strategic £5 million investment aimed at broadening its operational scope into small-scale sterile fill-finish. In 2023, after successfully completing the construction and qualification of a new GMP facility spanning 50,000 sqft, the UK-based CDMO is set to further…
No responses yet